TIFFANY KUCK: Open Payments
NPI 1770886491 · LINCOLN, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$934 in 66 payments from 15 companies in 2025. Trend: 2023 $620 · 2024 $1,294 · 2025 $934
Food & beverage: $934
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 37 | $417 |
| UROGEN PHARMA, INC. | 4 | $101 |
| Janssen Biotech, Inc. | 5 | $74 |
| PFIZER INC. | 4 | $64 |
| Novartis Pharmaceuticals Corporation | 3 | $53 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $37 |
| Laborie Medical Technologies Corp. | 1 | $33 |
| COLOPLAST CORP | 2 | $30 |
| Antares Pharma, Inc. | 2 | $29 |
| ABBVIE INC. | 1 | $19 |
Products named: ORGOVYX, GEMTESA, XTANDI, ERLEADA, PLUVICTO, ZUSDURI, JELMYTO, Nubeqa.
Industry payments across NE — which companies pay providers there.
